Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis

Background: Treatment of cancers with programmed cell death protein 1 (PD-1) pathway inhibitors can lead to immune-related adverse events (irAEs), which could be serious and even fetal. Therefore, clinicians should be aware of the characteristics of irAEs associated with the use of such drugs. Metho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Wang, Peng-Fei, Chen, Yang, Song, Si-Ying, Wang, Ting-Jian, Ji, Wen-Jun, Li, Shou-Wei, Liu, Ning, Yan, Chang-Xiang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651530/
https://ncbi.nlm.nih.gov/pubmed/29093678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00730
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados